DİŞ HEKİMLİĞİNDE ÇAPRAZ ENFEKSİYONLAR VE COVID-19
Enfeksiyon; virüsler, bakteriler veya mantarlar tarafından oluşturulan ateş, titreme, terleme, fonksiyon kaybı, şişlik ile karakterize olabilen bir yangıdır. Kendi karakteristik özelliğine bağlı olarak dokunma, aerasol, kan ve tükürük sıvıları gibi vücut sıvılarıyla bulaşan bu yangının ve buna sebep olabilecek mikroorganizmaların hasta – hekim - yardımcı personel arasındaki geçişi çapraz enfeksiyon olarak nitelendirilir. Çapraz enfeksiyonların hekimlerce tanınması; bulaşlarının engellenmesi ve yayılmaması için oldukça önemlidir. Bu derlemede diş hekimliğinde çapraz enfeksiyonlar ve son altı aylık dönemde coronavirüsün yeni tipi olarak karşımıza çıkan Covid-19’a yönelik güncel durum ve önleyici ve koruyucu yöntemler incelenecektir.
CROSS INFECTIONS IN DENTISTRY AND COVID-19
Caused by viruses, bacteria or fungi, infection
is an inflammation that can be characterized by
fever, chills, sweating, loss of function. Based
on its characteristic feature, the transmission
of this inflammation, which is transmitted by
touch, aerosol, body fluids such as blood and
saliva, and the microorganisms that can cause it,
the transmission of this inflammation between
patient, physician and nurses is defined as cross
infection. Recognition of the cross infection by
physicians is very important for preventing the
infection and not spreading it. In this review,
we will investigate in preventative methods,
the current state of the Covid-19, which we
face with as the new type of coronavirus in
the last six months, and the cross infections in
dentistry.
___
- 1. Atalay Y, Asutay F, Çakmak Ö. Diş hekimliği
ve çapraz enfeksiyon kontrolü. Kocatepe
Üniversitesi Diş Hekimliği Fakültesi Dergisi
2004;116:4-12.
2. Montebugnoli L, Dolci G, Spratt DA,
Puttaiah R. Failure of anti-retraction valves
and the procedure for between patient flushing:
a rationale for chemical control of dental
unit waterline contamination. Am J Dent
2005;18:270-4.
3. CDC. Recommended infection-control
practices for dentistry. MMWR recommendations
and reports 1993; 28:2-10.
4. https://covid19.who.int/ (01.05.2020)
5. World Health Organization. Report of the
WHO – China Joint Mission on Coronavirus
Disease 2019 (COVID-19). https://www.who.
int/docs/default-source/coronaviruse/whochina-
joint-mission-on-covid-19-final-report.
pdf/ (01.05.2020)
6. Lu R, Zhao X, Li J, Niu P, Yang B, Wu
H, Wang W, Song H, Huang B, Zhu N, et al.
Genomic characterisation and epidemiology of
2019 novel coronavirus: implications for virus
origins and receptor binding. Lancet 2020;
395:565–74.
7. Chan JF, Yuan S, Kok KH, To KK, Chu H,
Yang J, Xing F, Liu J, Yip CC, Poon RW, et
al. A familial cluster of pneumonia associated
with the 2019 novel coronavirus indicating
person-to-person transmission: a study of a
family cluster. Lancet. 2020;395:514–23
8. Thome G, Bernandes S, Guandalini S,
Guimares MCV. Dental Kliniklerde en iyi
Biyogüvenlik Uygulamaları İçin Yönergeler
1. Baskı. Curitiba: Facultad Ilapeo yayınları (e
-kitap), 2020:8-18.
9. Guan W, Ni Z, Hu Y, et al. Clinical characteristics
of 2019 novel coronavirus infection in China.
medRxiv. Available at: https://www.medrxiv.
org/content/10.1101/2020.02.06.20020974v1
(01.05.2020)
10. Rothe C, Schunk M, Sothmann P, et al.
Transmission of 2019-nCoV infection from an
asymptomatic contact in Germany. N Engl J
Med 2020;382:970–1.
11. https://www.who.int/news-room/q-a-detail/
q-a-coronaviruses/ 01.05.2020)
12. Vinayachandran, D., Balasubramanian, S.
Is Gustatory Impairment the First Report of an
Oral Manifestation in COVID‐19?. Oral Dis
2020.
13. Xu H, Zhong L, Deng J, et al. High
expression of ACE2 receptor of 2019-nCoV on
the epithelial cells of oral mucosa. Int J Oral
Sci. 2020;12(1):8.
14. Khot WY, Nadkar MY. The 2019 Novel
Coronavirus Outbreak–A Global Threat. J
Assoc Physicians India 2020;68(3):67.
15. Tonnesen P, Marott JL, Nordestgaard B,
Bojesen SE, Lange P. Secular trends in smoking
in relation to prevalent and incident smokingrelated
disease: A prospective population-based
study. Tob Induc Dis 2019;17:22.
16. Zhou Z, Chen P, Peng H. Are healthy
smokers really healthy? Tob Induc Dis
2016;14:35.
17. Park JE, Jung S, Kim A. MERS transmission
and risk factors: a systematic review. BMC
Public Health 2018;18(1):574.
18. Arcavi L, Benowitz NL. Cigarette
smoking and infection. Arch Intern Med.
2004;164(20):2206-2216.
19. Wang Y, Wang Y, Chen Y, Qin Q. Unique
epidemiological and clinical features of the
emerging 2019 novel coronavirus pneumonia
(COVID-19) implicate special control
measures. J Med Virol 2020.
20. https://www.icisleri.gov.tr/sehir-giriscikistebirleri-
ve-yas-sinirlamasi (01.05.2020)
21.http://web.shgm.gov.tr/documents/
sivilhavacilik/files/Covid-19/27-03-2020-
NOTAM-COVID-19.pdf (01.05.2020)
22. Paules CI, Marston HD, Fauci AS.
Coronavirus infections—more than just the
common cold. JAMA. 2020;323(8):707–708.
23. Centers for Disease Control and
Prevention. Infection control: severe acute
respiratory syndrome coronavirus 2 (SARSCoV-
2). Available at: https://www.cdc.gov/
coronavirus/2019-ncov/infection-control/
control-recommendations.html (01.05.2020)
24. Viroj Wiwanitkit MERS-CoV, surgical
mask and N95 respirators Singapore Med J
2014;55(9):507.
25. van Doremalen N, Bushmaker T, Morris
D, Holbrook M, Gamble A, Williamson B,
Tamin A, Harcourt J, Thornburg N, Gerber S.
et al. Aerosol and surface stability of HCoV-19
(SARS-CoV-2) compared to SARS-CoV-1. N.
Engl. J Med 2020;382:1564-1567.
26. Baseer M.-A, Ansari S.-H, AlShamrani S.-
S, Alakras A.-R, Mahrous R, Alenazi A.-M.
Awareness of droplet and airborne isolation
precautions among dental health professionals
during the outbreak of corona virus infection in
Riyadh city, Saudi Arabia. Journal of clinical
and experimental dentistry 2016;8(4):379-
387.)
27.http://www.tdb.org.tr/userfiles/files/
S B _ H a l k _ S a g l i g i _ G e n _ M u d _ 1 5 7 . p d f
(01.05.2020)
28.http://www.tdb.org.tr/userfiles/files/
S B _ H a l k _ S a g l i g i _ G e n _ M u d _ 1 9 0 . p d f
(01.05.2020)
29. Garner JS, Hospital Infection Control
Practices Advisory Committee Guideline
for isolation precautions in hospitals. Infect
Control Hosp Epidemiol. 1996;17(1):53–80.
30. To K., Tsang O., Chik-Yan Yip, C, Chan,
K. H., et al.Consistent detection of 2019 novel
coronavirus in saliva. Clin Infect Dis. 2020;12.
31. Cleveland JL. et al. Transmission of
blood-borne pathogens in US dental health
care settings: 2016 update. J Am Dent Assoc.
2016;147(9):729-38.
32. Yuan X, Xu J, Hussain S, Wang H, Gao N,
Zhang L. Trends and Prediction in Daily New
Cases and Deaths of COVID-19 in the United
States: An Internet Search-Interest Based
Model. Exploratory research and hypothesis in
medicine 2020;5(2):1–6.
33. Wadia R Transmission routes of
COVID-19 in the dental practice Br Dent J
2020;228(8):595.
34. https://edition.cnn.com/2020/03/30/world/
coronavirus-who-masks-recommendationtrnd/
index.html/ (01.05.2020)
3 5 . h t t p s : / / w w w. l i v e s c i e n c e . c o m / c d c -
recommends-face-masks-coronavirus.html
(01.05.2020)
36.https://www.cdc.gov/coronavirus/2019-
ncov/faq.html#How-to-Protect-Yourself
(01.05.2020)
37. https://www.icisleri.gov.tr/30-buyuksehirve-
zonguldaka-giriscikislar-daha-oncebelirlenen-
usul-ve-esaslara-gore-15-gunuzatildi/
(01.05.2020)
38. Zhou ZG, Yue DS, Mu CL, Zhang, L.
(2020), Mask is the possible key for selfisolation
in COVID‐19 pandemic. J Med Virol.
2020.
39. Centers for Disease Control and Prevention
recommendations for putting on and removing
personal protective equipment for treating
COVID-19 patients. From: https://www.
cdc.gov/hai/pdfs/ppe/ppe-sequence.pdf./
(17.03.2020)
40. Izzetti R, Nisi M, Gabriele M, Graziani F.
COVID-19 Transmission in Dental Practice:
Brief Review of Preventive Measures in Italy.
Journal of Dental Research. 2020.
41. Meng L, Hua F. Coronavirus disease 2019
(COVID-19): emerging and future challenges
for dental and oral medicine. J Dent Res
2020;12: 22034520914246.
42. Watts K, Balzer S, Drum M, et al. Ibuprofen
and acetaminophen versus intranasal ketorolac
(Sprix) in an untreated endodontic pain model:
a randomized, double-blind investigation. J
Endod 2019;45:94–8.
43. Smith EA, Marshall JG, Selph SS,
Barker DR, Sedgley CM. Nonsteroidal antiinflammatory
drugs for managing postoperative
endodontic pain in patients who present with
preoperative pain: a systematic review and
meta-analysis. J Endod 2017;43:7–15.
44. Taggar T, Wu D, Khan AA. A randomized
clinical trial comparing 2 ibuprofen
formulations in patients with acute odontogenic
pain. J Endod 2017;43:674–8.
45. Liesinger A, Marshall FJ, Marshall JG.
Effect of variable doses of dexamethasone
on posttreatment endodontic pain. J Endod
1993;19:35–9.
46. Alhazzani W, Møller MH, Arabi YM, et
al. Surviving Sepsis Campaign: guidelines
on the management of critically ill adults
with Coronavirus Disease 2019 (COVID-19).
Intensive Care Med 2020;1‐34.
47. Wong JG, Cheung EP, Cheung V, Cheung
C, Chan MT, Chua SE, McAlonan GM, Tsang
KW, Ip MS. Psychological responses to the
SARS out-break in healthcare students in Hong
Kong. Med Teach 2004;26(7):657–659.
48. Arduino PG, Conrotto D, Broccoletti R.
The outbreak of Novel Coronavirus disease
(COVID-19) caused a worrying delay in the
diagnosis of oral cancer in north-west Italy: the
Turin Metropolitan Area experience Oral Dis.
2020;10.1111/odi.13362.
49. Mallineni, SK, Innes, NP, Raggio, DP,
Araujo, MP, Robertson, MD, Jayaraman,
J. Coronavirus disease (COVID‐19):
Characteristics in children and considerations
for dentists providing their care. Int J Paediatr
Dent. 2020;30:245– 250.
50. Amirian ES Potential Fecal Transmission
of SARS-CoV-2: Current Evidence and
Implications for Public Health. Int J Infect Dis..
pii: S1201-9712(20)30273-3. doi: 10.1016/j.
ijid.2020.04.057
51. Ahmed MA, Jouhar R, Ahmed N, Adnan
S, Aftab M, Zafar MS, Khurshid Z. Fear
and Practice Modifications among Dentists
to Combat Novel Coronavirus Disease
(COVID-19) Outbreak. Int. J. Environ. Res.
Public Health 2020;17: 8.